Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
All articles — 31207 total
Edwards Lifesciences reported third-quarter results on the evening of November 4, arriving with the analyst community more aligned to the upside than at any prior point in 2026, and options traders having made the…
Eaton reported Q3 results on November 3 and jumped 7% in a single session, closing at $391.70, a sharp reversal from the pre-earnings selloff that had dragged the stock down more than 14% over the prior month. The…
Eastman Chemical dropped 2.2% on Tuesday to close at $65.34, underperforming a peer group that gained a median 2.7% on the week, with the November 5 earnings report now less than 24 hours away. The most notable shift…
EOG Resources fell 3.7% over the past week to $155.17, a softer drop than the 5% to 7% losses across its closest E&P peers, with Thursday's earnings report now two days away. The peer contrast is worth spelling out.…
DIS short sellers have added meaningfully to positions over the past week, pushing short interest to its highest level in over a month, even as the lending market remains comfortably loose and the stock has gained…
Deere & Company enters its November 25 earnings report with the stock up 4.1% on the week to $665.83, yet options traders have quietly shifted more defensive than usual, creating an interesting contrast with what…
Deckers Outdoor enters November with two distinct forces pulling against each other: short sellers cutting positions after a bruising earnings period, while a near-certain index reclassification sets up a mechanical…
D.R. Horton, America's largest homebuilder by volume, fell 5% on Tuesday to $145.23, a steeper single-day drop than any of its close peers, while the broader homebuilder group pulled back 3% to 4% on the day. The gap…
Crown Holdings enters November with a sharp analytical divide on its hands. The stock has surged 13.8% over the past month to $120.73, yet JP Morgan chose this week to pull back from its bullish stance, cutting to…
GLW recovered 2.4% on Tuesday to close at $126.14, a small reprieve after a month that erased nearly a quarter of its market value, and the question now is whether the stock has genuinely found a floor or is simply…
FIX staged its biggest single-day recovery in months on November 3, jumping 7.1% to $1,285.13. The move matters because the stock had shed more than 25% over the prior month, and the question now is whether this is a…
Colgate-Palmolive enters the post-earnings week with the Street in an unusually unified mood, nearly every major firm raising its price target after the October 30 print delivered a 4.6% single-day gain. The analyst…
Citigroup drifts into the first week of November with the same tension that defined October: a broadly bullish analyst consensus sitting above a stock that has fallen 4.5% over the past month and whose options market…
Charles River Laboratories International has now posted its Q3 results, and the data picture that dominated the preview note has shifted in one important direction: short sellers are continuing to cover even as options…
Caterpillar has fallen 12.5% in a week, to $623.94, after Q3 results landed on October 29 with a one-day drop of nearly 13%, the sharpest single-session move in recent memory for a company this size. The earnings…
CBT has just reported its fiscal fourth-quarter results, and the market's immediate reaction confirms what the most extreme options positioning in a year was signalling: a sharp repricing downward. The options market…
CVS Health Corporation reported Q3 results on Wednesday, and the week's most telling signal is that options positioning reached its most defensive level of the past year on the day of the print, even as short sellers…
MTRN closed its earnings day with a 4.9% jump to $227.43, yet the stock has still shed 27% over the past month, leaving the bulls arguing over whether a floor is forming or the selloff has further to run. The…
BRKR enters the week after a fresh earnings print carrying a split message: the Street's most closely watched firm just moved to the sidelines, while short sellers have been quietly reducing exposure for a month. The…
The single most telling number on Boston Scientific this week is not the short interest, which at 2.7% of float remains unremarkable. It is the put/call ratio, which jumped to 0.63 on November 3, more than 3.6 standard…
